DRKS00029028已完成不适用
Immunotherapy Proof-of-Concept Study - Determination of miRNA biomarkers to predict response and autoimmune complications in lung cancer patients treated with immune checkpoint inhibitors.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Male or female patient older than 18 years whose suitable blood samples are available at the Lung Biobank Heidelberg.
- •- Diagnosed stage IV lung cancer
- •- Treatment with immune checkpoint inhibitor (anti-PD1 or anti-PD-L1 antibody, e.g. nivolumab, pembrolizumab or atezolizumab).
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
An exploratory clinical trial of immunotherapy before surgery in stomach cancer casestage I-III stomach cancerJPRN-UMIN000002919JIKEI UNIVERSITY SCHOOL OF MEDICINE50
已完成
3 期
A Clinical trial of Omicron-Based CovIran Barkat vaccine as a third injection dose in vaccinated population over 18 years of ageIRCT20171122037571N4SHIFAPHARMED Industrial Group Co210
进行中（未招募）
1 期
Clinical evaluation of virus therapy for cancerColorectal, ovarian, pancreatic, gallbladder and bile duct cancerMedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000004864EUCTR2017-002565-22-SEokon Pharma AB80
进行中（未招募）
不适用
Klinische Studie zur Überprüfung der Immunogenität unterschiedlicher Varianten einer FSME-Schnellimmunisierung mit inaktiviertem Frühsommer-Meningoenzephalitis-Impfstoff - FSME-Schnellimmunisierungs-StudieEUCTR2006-006955-10-ATniv.-Prof. Dr. Helmut Mittermayer108
招募中
不适用
A Pilot Study of Adoptive Immunotherapy Comprising 2-Methyl-3-Butenyl-1-Pyrophosphate-Stimulated Gamma Delta T Cells in Patients With advanced Renal Cell Carcinomaadvanced Renal cell carcinomaJPRN-UMIN000016793Tokyo Women's Medical University10